Broadening its existing partnership, Danisco has extended its licensing agreement with Fonterra Cooperative Group for two probiotic bacteria cultures. The agreement covers the production and marketing of HOWARU Bifido and Rhamnosus, with the new terms extending from five to 10 years. The agreement also expands territory and applications, meaning global access for dairy products, liquid and powdered beverages, such as juices, waters and sports drinks, dietary supplements, meats, cheeses, cereals, confectionery and straws. In addition, there will no longer be restrictions on therapeutic fields, thus broadening the scope for the development of clinical studies and health claims.